Contact info@epaad.org for more information

ApoE and TDP-43

by | Feb 2, 2022 | Publications

Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43. Wennberg, A. M., Tosakulwong, N., Lesnick, T. G., Murray, M. E., Whitwell, J. L., Liesinger, A. M., Petrucelli, L., Boeve, B. F., Parisi, J. E., Knopman, D. S., Petersen, R. C.,...

ApoE and α-synuclein

by | Feb 2, 2022 | Publications

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008).  Nature neuroscience, 11(3), 301308. α-Synuclein Interacts with Lipoproteins in Plasma. Emamzadeh, F. N., &...

ApoE and Other Diseases

by | Feb 2, 2022 | Publications

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Peila, R., Rodriguez, B. L., Launer, L. J., & Honolulu-Asia Aging Study (2002).  Diabetes, 51(4), 12561262. The association between apolipoprotein E gene...

ApoE and Other Neurodegenerative Disorders

by | Feb 2, 2022 | Publications

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Robinson, J. L., Lee, E. B., Xie, S. X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van Deerlin, V. M., Yan, N., Yousef, A., Hurtig, H. I., Siderowf, A.,...